Prelude Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $38k | 30k | 1.28 |
| 2024-09-30 | $57k | 27k | 2.10 |
| 2024-06-30 | $56k | 15k | 3.84 |
| 2024-03-31 | $97k | 20k | 4.76 |
| 2023-12-31 | $131k | 31k | 4.29 |
| 2023-09-30 | $42k | 13k | 3.15 |
| 2023-06-30 | $27k | 6.1k | 4.46 |
| 2023-03-31 | $59k | 10k | 5.67 |
| 2022-12-31 | $559k | 91k | 6.16 |
| 2022-09-30 | $34k | 5.2k | 6.65 |
| 2022-06-30 | $21k | 4.1k | 5.17 |
| 2022-03-31 | $40k | 5.9k | 6.81 |